Fulgent Genetics Inc. (FLGT)
17.06
0.21 (1.25%)
At close: Mar 28, 2025, 3:59 PM
17.11
0.29%
After-hours: Mar 28, 2025, 06:20 PM EDT
Fulgent Genetics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY01 |
| Revenue | 283.47M | 289.21M | 618.97M | 992.58M | 421.71M | 32.53M | 21.36M | 18.73M | 18.28M | 9.58M | 1.28M | n/a |
| Cost of Revenue | 176.25M | 184.76M | 252.07M | 215.53M | 89.81M | 14.11M | 10.69M | 8.55M | 6.72M | 5.07M | 936K | n/a |
| Gross Profit | 107.22M | 104.46M | 366.9M | 777.05M | 331.9M | 18.42M | 10.66M | 10.18M | 11.55M | 4.51M | 342K | n/a |
| Operating Income | -73.92M | -72.69M | 178.53M | 675.95M | 290.16M | -428K | -5.06M | -3.4M | 919K | -5.01M | -990K | 104.34M |
| Interest Income | 31.3M | 21.44M | 5.5M | 1.35M | 1.53M | 837K | 434K | 481K | 1K | 27K | n/a | n/a |
| Pretax Income | -51.96M | -174.09M | 184.03M | 677.3M | 291.68M | 409K | -4.62M | -2.92M | -4.47M | -4.99M | -990K | 104.34M |
| Net Income | -42.71M | -167.82M | 143.4M | 507.36M | 214.31M | 366K | -4.49M | -2.66M | -5.39M | -8.31M | -4.28M | 104.34M |
| Selling & General & Admin | 124.35M | 130.47M | 149.99M | 75.17M | 30.17M | 12.31M | 10.19M | 9.36M | 7.08M | 5.09M | 811K | n/a |
| Research & Development | 48.82M | 41.44M | 28.91M | 24.22M | 11.58M | 6.54M | 5.53M | 4.22M | 3.56M | 4.43M | 521K | n/a |
| Other Expenses | 7.96M | n/a | 6.5M | 1.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 104.34M |
| Operating Expenses | 181.13M | 299.4M | 185.4M | 101.1M | 41.75M | 18.85M | 15.72M | 13.58M | 10.64M | 9.52M | 1.33M | 104.34M |
| Interest Expense | 170K | n/a | 5.5M | n/a | n/a | n/a | n/a | n/a | 5.39M | n/a | n/a | n/a |
| Selling & Marketing Expenses | 36.25M | 41.47M | 38.92M | 24.44M | 14.95M | 5.9M | 4.65M | 4.22M | 2.47M | 2.67M | 581K | n/a |
| Cost & Expenses | 357.39M | 484.74M | 437.47M | 316.63M | 131.55M | 32.96M | 26.41M | 22.13M | 17.36M | 14.59M | 2.27M | 104.34M |
| Income Tax | -8.14M | 1.15M | 42.1M | 174.79M | 72.53M | 43K | -1.07M | -768K | 920K | 3.33M | 3.29M | n/a |
| Shares Outstanding (Basic) | 30.23M | 29.78M | 30.1M | 29.41M | 22.69M | 18.71M | 17.98M | 17.74M | 17.68M | 12.77M | 12.77M | 29.96M |
| Shares Outstanding (Diluted) | 30.23M | 29.78M | 30.96M | 30.98M | 24.06M | 18.71M | 17.98M | 17.74M | 17.68M | 12.77M | 12.77M | 31.2M |
| EPS (Basic) | -1.41 | -5.63 | 4.76 | 17.13 | 9.64 | 0.02 | -0.25 | -0.15 | -0.3 | -0.65 | -0.34 | 3.48 |
| EPS (Diluted) | -1.41 | -5.63 | 4.63 | 16.26 | 9.09 | 0.02 | -0.25 | -0.15 | -0.3 | -0.65 | -0.34 | 3.34 |
| EBITDA | -73.92M | -46.55M | 221.59M | 675.95M | 290.16M | 1.68M | -2.91M | -1.75M | 2.09M | -4.44M | -794K | 104.34M |
| Depreciation & Amortization | n/a | 26.14M | 36.91M | 12.16M | 3.37M | 2.52M | 2.16M | 1.73M | 1.17M | 575K | 196K | n/a |